Serum (anti-PLA2R Ab and anti-THSD7A Ab) and urine anti-PLA2R Ab are essential biomarkers for diagnosis, treatment decision and prognosis of patients with primary MGN. Here, PLA2R1 is linked to idiopathic membranous glomerulonephritis.